Apr-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Emprise Canada has demonstrated varying performance across different categories and provinces. In Alberta, the brand's presence in the Capsules category has seen a slight decline, moving from 4th place in January to 6th place by April 2025. This downward trend is accompanied by a decrease in sales figures, indicating potential challenges in maintaining market share. Conversely, in the Edible category within the same province, Emprise Canada experienced a brief dip in March but managed to recover to 18th place in April. This suggests a potential for stabilization or growth in the Edible sector despite the overall competitive landscape.
In British Columbia, Emprise Canada has maintained a strong and consistent position in the Capsules category, holding steady at 2nd place from January to April 2025. This stability is significant, particularly when compared to their performance in the Oil category, where they improved their ranking from 12th in January to 10th in April, alongside an increase in sales. Meanwhile, in Ontario, the brand has consistently held the 5th position in the Capsules category, while showing a positive trend in the Oil category by improving its ranking from 18th to 15th. Notably, in Saskatchewan, Emprise Canada has made a notable entry into the Oil category, securing a 5th place ranking by April, which may indicate a new area of growth potential.
Competitive Landscape
In the competitive landscape of the Ontario cannabis capsules market, Emprise Canada consistently holds the 5th rank from January to April 2025. This stable position places it behind notable competitors such as Tweed and Glacial Gold, which maintain their 3rd and 4th ranks respectively throughout the same period. Despite a consistent rank, Emprise Canada's sales figures show a slight decline from January to February, followed by a recovery in March and a slight dip again in April. This trend suggests that while Emprise Canada maintains its market position, it faces challenges in increasing its sales volume against strong competitors. Meanwhile, Indiva and Decimal trail behind Emprise Canada, consistently ranking 6th and 7th, indicating a competitive edge for Emprise Canada in maintaining its mid-tier market position.
Notable Products
In April 2025, the top-performing product for Emprise Canada was THC Light Year Softgels 30-Pack (300mg) in the Capsules category, maintaining its first-place rank consistently across all months with a notable sales figure of 3188. The CBD/THC 1:1 Softgels 15-Pack (150mg CBD, 150mg THC), also in the Capsules category, held steady in second place, showing resilience after a dip in February. Rapid- Blue Raz Indica Gummy (10mg) in the Edible category ranked third, experiencing a slight decline in sales from March but maintaining its position. The Rapid - Grape Sativa Soft Chew (10mg), another Edible, dropped from second in February to fourth in April, indicating a shift in consumer preference. Lastly, the CBN/CBD 1:5 Softgels 30-Pack (300mg CBN, 1500mg CBD) remained stable in fifth place, demonstrating consistent demand despite fluctuations in earlier months.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.